Scientists behind a world-first gene therapy reveal how they teamed up with experts across academia and industry to produce a ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, ...

In the quest to design vaccines that better help the body's immune system fight disease, scientists are always looking for ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, ...

Major study milestone highlights START's commitment to bringing novel cancer therapies to patients through community-based early-phase clinical trials SAN ANTONIO, May 15, 2025 /PRNewswire/ -- The ...

Downstream processing for mRNA manufacturing is currently too complex, but simplifying by using precipitation looks promising.

The first dose was administered at START San Antonio by Dr. Amita Patnaik who shared, "mRNA represents a bold new frontier in cancer immunotherapy, and we're proud to provide our patients access ...

A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...